newsfilter
← Latest News
GlobeNewswire·

ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million

  • ENvue Medical (NASDAQ: FEED) signed an exclusive distribution agreement with Peak Medical to expand UroShield® sales in the United Kingdom & Republic of Ireland.
  • The agreement covers the period through December 31, 2029, with an option to renew for an additional three years.
  • Minimum purchase commitments total approximately $2.6 million (£2.1 million) over the initial term.
  • Product volumes are projected to grow from 650 units in 2026 to 35,000 units in 2029.
  • UroShield® utilizes proprietary low-intensity surface acoustic wave (SAW) technology to prevent catheter-associated infections.
  • The NanoVibronix product line includes UroShield® & PainShield®, designed for home or care settings.
  • ENvue Medical is headquartered in Tyler, Texas, with R&D operations in Tel Aviv, Israel, & manufacturing in the US.
  • The company also operates the ENvue™ Navigation Platform for minimally invasive feeding tube placement.